Warren Point Capital, LLC was created to access and acquire minority positions in select emerging growth medical technology companies. WPC leverages a global network to identify and advise capital efficient portfolio companies approaching near-term value-inflection points. Founded in 2020, WPC has invested in over a dozen med-tech companies.
THE INFORMATION ON THIS PAGE IS INTENDED FOR THE MANAGEMENT OF GROWTH COMPANIES INTERESTED IN PARTNERING WITH WARREN POINT CAPITAL. IT IS NOT APPROPRIATE FOR ANY CURRENT OR PROSPECTIVE INVESTORS IN A WPC INVESTMENT VEHICLE AND SHOULD NOT BE CONSIDERED AN ACTUAL OR IMPLIED ENDORSEMENT OF ANY ADVICE, ANALYSIS, REPORT OR OTHER SERVICE RENDERED BY WPC.
Company Details
- Employees
- 2
- Founded
- 2020
- Address
- Santa Barbara, Ca 93101, Us
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Keywords
- RENDERED BY WPC..
- HQ
- Santa Barbara, CA
Warren Point Capital Questions
Warren Point Capital's website is http://www.warrenpointcapital.com
Warren Point Capital's LinkedIn profile is https://www.linkedin.com/company/warren-point-capital
Warren Point Capital has
2 employees.
View email and phone details for 2
employees at Warren Point Capital.
Warren Point Capital's industry is
Venture Capital and Private Equity Principals
Warren Point Capital's top competitors are
New Enterprise Associates (Nea),
Cormorant Asset Management, Lp,
Advent Life Sciences,
Vertex Ventures Hc,
Infocus Capital Partners,
Morgenthaler Venture Partners V, L.p.,
Femhealth Ventures,
Moximed,
Elevage Medical Technologies,
Morgenthaler.
Warren Point Capital's categories are Venture Capital and Private Equity Principals
Warren Point Capital's founding year is 2020
